How to Buy Labcorp Holdings Stock
Labcorp Holdings Inc
Labcorp Holdings is a diagnostic & research company located in North Carolina, United States, which is part of the Healthcare sector, and is traded under the ticker LH on the NYSE exchange.
Labcorp Holdings stock last closed at $252.33, down 2.14% from the previous day, and has increased 11.08% in one year. It has overperformed other stocks in the Diagnostics & Research industry by 0.02 percentage points. Labcorp Holdings stock is currently +20.52% from its 52-week low of $209.38, and -14.09% from its 52-week high of $293.72.
At the moment, there are 82.9M shares of LH outstanding. The market capitalization of LH is $20.92B. In the last 24 hours, 970,000 LH shares were traded.
How to Buy Labcorp Holdings Stock
Not sure how to invest in Labcorp Holdings stock? Here's how.
- Figure out where to buy Labcorp Holdings stock: You need to decide on an online brokerage, but don't worry - we've sifted through dozens of online stock brokerages and apps to help you decide where to buy Labcorp Holdings stock.
- Open your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've selected.
- Put funds into your brokerage account: Pick your payment method and add your information.
- Research Labcorp Holdings stock: The Labcorp Holdings ticker symbol is LH. Is Labcorp Holdings stock a good investment? Should you buy shares of LH? How do LH's underlying business fundamentals look? Do top analysts think Labcorp Holdings is a good buy? Why has LH's stock price moved recently? (Hint: Our stock analysis website can help you understand if LH is a good stock to buy).
- Make your LH buy order: Decide if you will purchase LH shares at the current market price or use a limit order to purchase LH stock at a particular price.
- Track your LH position: Create a watchlist to the latest updates on your new investment in Labcorp Holdings stock.
Step 1: Figure out where to buy Labcorp Holdings stock
You will need an online brokerage account in order to access the NYSE market and buy LH stock.
Our preferred brokerage: eToro
In our opinion, eToro is the best place to buy stocks. eToro gives you:
- You can invest in stocks with 0% commissions: Invest without commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still buy the stock.
- Access to global financial markets: From Technology to Real Estate, New York to Tokyo (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's leading exchanges.
- Social investing: eToro offers a community of more than 20 million users around the world. Talk to, learn from, and copy the unique crypto portfolios of top investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other financial assets: Such as ETFs and cryptocurrencies.
Get $10 towards your stock purchase by signing up for an account with eToro now. This offer is only for US users.
Open eToro AccountStep 2: Open your brokerage account
Now that you've chosen the best brokerage, the next step is to fill out some personal info so you are able to invest in LH stock today.
How to Create a New Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Enter your personal details to start your new brokerage account.
- Send your details by pressing the "Create Account" button. Get started with eToro today
Step 3: Put funds into your brokerage account
Now that you have filled out your info on the best stock trading app for beginners, your next step is to transfer the money for your investment:
Watch the walkthrough below if you need help depositing money into your investment account.
Step 4: Research Labcorp Holdings stock
After you have identified the best place to buy Labcorp Holdings stock, it's important to analyze their stock before you invest, so you truly wrap your head around the risk as well as the upside.
Labcorp Holdings Numbers
Labcorp Holdings Overview
WallStreetZen was built to help average investors perform better fundamental analysis in less time.
You can view all of the due diligence checks on LH's stock page.
Is LH stock undervalued?
You can use a variety of different financial metrics, analyses, models, and charts to gauge LH's intrinsic value.
Using relative valuations measures:
- LH could be overvalued based on its P/E ratio of 24.62x, relative to Diagnostics & Research industry P/E ratio of 22.63x
- LH could be undervalued based on its P/B ratio of 2.41x, relative to Diagnostics & Research industry P/B ratio of 4.26x
- LH may be undervalued based on its PEG ratio of 0.82x
You can do more valuation analysis on LH's stock here.
LH Financial Overview
Positive Health Checks:
- There are more short-term assets than short-term liabilities on the LH balance sheet.
- LH earnings of $1.33B is not enough to cover its interest payments.
- LH's operating cash flow of $1.80B allows it to safely service it's debt of $6.53B.
- Total LH debt is lower than 5 years ago, relative to shareholder equity.
- LH profit margin has gone up from 3.4% to 6.2% in the past year.
Negative Health Checks:
- There are more long-term liabilities than short-term assets on the LH balance sheet.
- LH has a relatively high debt to equity ratio of 1.1.
Do Wall Street analysts think it's a good time to buy LH stock
Out of 8 Wall Street analysts who give ratings on LH, the consensus analyst rating on LH is a Buy
Please keep in mind that analyst ratings are not stock recommendations, nor are they investment advice.
Latest LH Analyst Forecasts
Ricky Goldwasser, a top 11% analyst from Morgan Stanley maintains LH with a strong buy rating and raises their LH price target from $283.00 to $306.00, on Jul 25, 2025.
Morgan Stanley's Ricky Goldwasser raised their price target on Labcorp Holdings (NYSE: LH) by 8.1% from $283 to $306 on 2025/07/25. The analyst maintained their Strong Buy rating on the stock.
Labcorp Holdings reported its Q2 2025 earnings.
"Impressive" Biopharma experience and organic volume growth helped boost the stock price post-print in spite of high expectations ahead of the results, Goldwasser told readers.
Moving into 2H, the analyst said they see "encouraging" higher utilization.
Earnings Report
For Q2 2025, Labcorp Holdings reported:
- EPS of $4.35, which beat the Zacks Consensus Estimate of $4.14 and Q2 2024's $3.94.
- Revenue of $3.53B, which beat the Zacks Consensus Estimate by 1.14% and Q2 2024's $3.22B.
For FY 2025, management guided:
- EPS of $16.05 to $16.50, up from the prior $15.70 to $16.40.
- 7.5% to 8.6% revenue growth, up from the prior 6.7% to 8%.
Chairman & CEO Adam Schechter commented: "Labcorp had a very strong second quarter, delivering double-digit topline growth, while expanding margins across both segments.
"We brought innovative tests to market, and applied our leadership in science and technology to drive growth, enhance the customer experience and improve our operations.
"We remain committed to delivering sustained value to our customers, employees and shareholders as we execute on our long-term strategy.
"Based upon our performance in the first half and our momentum going into the second half of the year, we're raising our guidance."
Eric Coldwell, a top 23% analyst from Baird maintains LH with a buy rating and raises their LH price target from $290.00 to $302.00, on Jul 25, 2025.
David Westenberg, a top 6% analyst from Piper Sandler maintains LH with a hold rating and raises their LH price target from $260.00 to $280.00, on May 6, 2025.
You can dive deeper into what analysts are projecting on the Labcorp Holdings stock forecast page.
LH Technicals
Is LH Growing Revenue?
Last year, LH earnings were $855.20M. Over the past 5 year, LH's earnings have gone up by 3.4% per year. This was slower than the Diagnostics & Research industry average of 8.66%.
Last year, LH revenue was $13.77B. In the past five year, LH's revenue has increased by 2.04% per year. This was slower than the Diagnostics & Research industry average of 9.2%.
Dig into LH's earnings and revenue performance here.
Latest Insiders Trades at LH
Over the past year, executives and large shareholders at LH have sold more shares than they have bought.
Megan D. Bailey, EVP Pres Central Labs Intl of LH, was the latest LH insider to sell. They sold $46,153.36 worth of LH stock on Nov 3, 2025.
Learn more about who owns LH stock here.
Does LH stock generate passive income?
Labcorp Holdings pays a dividend of 1.14%, compared to the Diagnostics & Research industry's average dividend yield of 0.66%. If you owned $1,000 of LH stock, you would have received $11.41 last year.
Labcorp Holdings dividend payments have not consistently grown over the past decade but have remained stable.
Get more info about Labcorp Holdings dividend yield and history here.
LH Social Trading Data
One of the reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to see what other investors have to say.
Step 5: Make your LH buy order
There are two main types of orders:
- Market order: A market order is an order to buy or sell a stock at the best available price.
Market orders are mostly sufficient. - Limit order: A limit order allows you to buy or sell a security at a specific price (or better).
If you want to be certain you're buying or selling at a given price, place a limit order.
Press the Open button and your broker will execute the order.
If you want additional info about buying stocks on eToro, watch the how to video below:
Step 6: Track your LH position
Now that you own some shares in LH, you'll want to stay up-to-date on your stock purchase.
Start a watchlist to get notified of important updates regarding your LH stock.
LH Feed
How to Buy Stock in Labcorp Holdings
To summarize, here are the 6 steps to buy stock in Labcorp Holdings:
- Figure out where to buy Labcorp Holdings stock
- Open your brokerage account
- Put funds into your brokerage account
- Research Labcorp Holdings stock
- Make your LH buy order
- Track your LH position
If you need a brokerage account, eToro is our favorite venue.
Get Started with eToro TodayIf you want to watch your investment in Labcorp Holdings, click below.
Other Stock Buying Guides You May Enjoy
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.